StockNow
Log in
U.S. Markets

Johnson & Johnson (JNJ) commits USD 5.5bln to its talc litigation resolution, while resolution eliminates litigation of 76,000 of ovarian tout claims

StockNow breaking-news AI analysis

JNJ committed $5.5 billion to resolve 76,000 talc-related ovarian cancer claims, a move aimed at clearing a significant legal risk that has historically caused the stock to trade below its intrinsic value.

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYU.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)

Geopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement